Today news
About the same in other media
HC restrains Glenmark from selling asthma drug under 'Indamet' name
Reading now: 862
Delhi High Court on Monday in an interim order restrained generic drug maker Glenmark Pharmaceuticals from manufacturing, selling or advertising its asthma drug under the mark Indamet, which is allegedly identical or deceptively similar to Sun Pharma Laboratories' registered mark for its anti-diabetes drug «Istamet XR CP». Sun Pharma and Glenmark are contesting over their right to use drug names «Istamet» and «Indamet», respectively, which Sun Pharma finds to be deceptively similar and confusing.
Read more on economictimes.indiatimes.comAbout this in other media
Tim Hortons treats, beverages to be available at doorstep in Mumbai via Zomato from next month livemint.com /9 months ago
Buy tomatoes at Rs 80/kg: All the locations where the government is selling subsidized tomatoes economictimes.indiatimes.com /9 months ago
Flood: NDRF rescues bull worth Rs 1 crore from Noida economictimes.indiatimes.com /9 months ago
Show more
The website fvbb.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
